158 related articles for article (PubMed ID: 35183910)
1. Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
I Ghanem A; Woody NM; Schymick MA; Joshi NP; Geiger JL; Jillian Tsai C; Dunlap NE; Liu HY; Burkey BB; Lamarre ED; Ku JA; Scharpf J; Caudell JJ; V Porceddu S; Lee NY; Adelstein DJ; Koyfman SA; Siddiqui F
Oral Oncol; 2022 Mar; 126():105781. PubMed ID: 35183910
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment package time in head and neck cancer patients treated with adjuvant radiotherapy and concurrent systemic therapy.
Ghanem AI; Schymick M; Bachiri S; Mannari A; Sheqwara J; Burmeister C; Chang S; Ghanem T; Siddiqui F
World J Otorhinolaryngol Head Neck Surg; 2019 Sep; 5(3):160-167. PubMed ID: 31750429
[TBL] [Abstract][Full Text] [Related]
3. The effect of treatment package time on locally advanced oral cavity cancer outcomes.
Petery T; Frankart AJ; Esslinger H; Wu X; Rai SN; Takiar V
Oral Oncol; 2024 Jul; 154():106870. PubMed ID: 38823171
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
[TBL] [Abstract][Full Text] [Related]
5. Traditional risk factors and nodal yield-still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?
Butt Y; Tennstedt P; Busch CJ; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2023 Mar; 199(3):284-292. PubMed ID: 36350358
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration.
Babar A; Woody NM; Ghanem AI; Tsai J; Dunlap NE; Schymick M; Liu HY; Burkey BB; Lamarre ED; Ku JA; Scharpf J; Prendes BL; Joshi NP; Caudell JJ; Siddiqui F; Porceddu SV; Lee N; Schwartzman L; Koyfman SA; Adelstein DJ; Geiger JL
Curr Oncol; 2021 Jun; 28(4):2409-2419. PubMed ID: 34209302
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
[TBL] [Abstract][Full Text] [Related]
10. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
11. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
14. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
15. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
16. Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension.
de Almeida JR; Truong T; Khan NM; Su JS; Irish J; Gilbert R; Goldstein D; Huang SH; O'Sullivan B; Hosni A; Hope A; Waldron J; Hansen AR; Spreafico A; Siu LL; Perez-Ordonez B; Xu W; Weinreb I
Oral Oncol; 2020 Nov; 110():104845. PubMed ID: 32615441
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes after treatment of cancer of the oral cavity (1985-2015).
Zanoni DK; Montero PH; Migliacci JC; Shah JP; Wong RJ; Ganly I; Patel SG
Oral Oncol; 2019 Mar; 90():115-121. PubMed ID: 30846169
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.
George JR; Yom SS; Wang SJ
Laryngoscope; 2014 Jul; 124(7):1603-8. PubMed ID: 24318221
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
